GDUFA: Will Industry Self-Identification Push Lengthen The Backlog?

Facility list generated by industry submission likely will include plants that need to be inspected, potentially creating a larger backlog for FDA to clear, but GPhA expects remaining generic drug user fees should be announced by the Jan. 14 deadline.